Connect Biopharma Holdings annual operating margin
2024
2025
Connect Biopharma Holdings Operating Margin Growth & History (CNTB)
Connect Biopharma Holdings's operating margin was −90,740.63% for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −90,740.63% | −90654.38 pp |
| 2024 | 2024-12-31 | −86.24% | — |
Connect Biopharma Holdings quarterly operating margin
Q2.24
Q3.24
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −635.98% | +499.87 pp |
| Q1 2026 | 2026-03-31 | −11,601.78% | −11658.36 pp |
| Q3 2025 | 2025-09-30 | −110,481.25% | — |
| Q2 2025 | 2025-06-30 | −27,966.67% | — |
| Q3 2024 | 2024-09-30 | −1,135.85% | — |
| Q2 2024 | 2024-06-30 | 56.58% | — |
Connect Biopharma Holdings operating margin trends
Across the available reported history, Connect Biopharma Holdings's operating margin decreased from −86.24% to −90,740.63%, a change of −90654.38 percentage points. The latest reported quarter, Q2 2026, shows −635.98%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings filings at SEC.gov ↗